Skip to content

Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers

Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00685620
Acronym
CASA
Enrollment
463
Registered
2008-05-28
Start date
2002-08-31
Completion date
2007-02-28
Last updated
2017-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Abuse

Brief summary

Purpose of the project is to examine the effectiveness of Reinforcement-Based Treatment (RBT) on drug abuse and psychosocial outcomes of iner city opiate abusers who have recently completed a brief detoxification.

Detailed description

Participants are randomized into one of 3-groups: 1) those receiving intensive behavioral therapy plus abstinence-contingent housing, 2) those receiving recovery housing alone, and 3) those receiving standard care (referrals to community providers). For the two groups receiving recovery housing, rent payment is provided for a period of 3 months, as long as the participant remains drug-free.

Interventions

BEHAVIORALReinforcement Based Treatment

3 group random assignment to receive standard care, recovery housing alone, or recovery housing plus behavioral treatment

Sponsors

National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* opiate dependent agree to live in recovery housing

Exclusion criteria

* acute psychiatric disorder pregnant over 65

Design outcomes

Primary

MeasureTime frame
Drug abstinence at follow-up1, 3 and 6 months

Secondary

MeasureTime frame
Rates of employment1, 3, and 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026